203 related articles for article (PubMed ID: 25247900)
1. A review of the role of genetic testing in pain medicine.
Trescot AM; Faynboym S
Pain Physician; 2014; 17(5):425-45. PubMed ID: 25247900
[TBL] [Abstract][Full Text] [Related]
2. Genetics and implications in perioperative analgesia.
Trescot AM
Best Pract Res Clin Anaesthesiol; 2014 Jun; 28(2):153-66. PubMed ID: 24993436
[TBL] [Abstract][Full Text] [Related]
3. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.
Klepstad P; Fladvad T; Skorpen F; Bjordal K; Caraceni A; Dale O; Davies A; Kloke M; Lundström S; Maltoni M; Radbruch L; Sabatowski R; Sigurdardottir V; Strasser F; Fayers PM; Kaasa S;
Pain; 2011 May; 152(5):1139-1145. PubMed ID: 21398039
[TBL] [Abstract][Full Text] [Related]
4. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
Solhaug V; Molden E
Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
[TBL] [Abstract][Full Text] [Related]
5. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
Owusu Obeng A; Hamadeh I; Smith M
Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
[TBL] [Abstract][Full Text] [Related]
6. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics-guided analgesics in major abdominal surgery: Further benefits within an enhanced recovery protocol.
Senagore AJ; Champagne BJ; Dosokey E; Brady J; Steele SR; Reynolds HL; Stein SL; Delaney CP
Am J Surg; 2017 Mar; 213(3):467-472. PubMed ID: 27955884
[TBL] [Abstract][Full Text] [Related]
8. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis.
Ren ZY; Xu XQ; Bao YP; He J; Shi L; Deng JH; Gao XJ; Tang HL; Wang YM; Lu L
Pain Physician; 2015; 18(2):131-52. PubMed ID: 25794200
[TBL] [Abstract][Full Text] [Related]
9. The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.
Reynolds KK; Ramey-Hartung B; Jortani SA
Clin Lab Med; 2008 Dec; 28(4):581-98. PubMed ID: 19059064
[TBL] [Abstract][Full Text] [Related]
10. Codeine and opioid metabolism: implications and alternatives for pediatric pain management.
Chidambaran V; Sadhasivam S; Mahmoud M
Curr Opin Anaesthesiol; 2017 Jun; 30(3):349-356. PubMed ID: 28323671
[TBL] [Abstract][Full Text] [Related]
11. The pharmacogenetics of opioid treatment for pain management.
Singh A; Zai C; Mohiuddin AG; Kennedy JL
J Psychopharmacol; 2020 Nov; 34(11):1200-1209. PubMed ID: 32715846
[TBL] [Abstract][Full Text] [Related]
12. Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
Bell GC; Donovan KA; McLeod HL
Cancer Control; 2015 Oct; 22(4):426-32. PubMed ID: 26678969
[TBL] [Abstract][Full Text] [Related]
13. The genetic influences on oxycodone response characteristics in human experimental pain.
Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J
Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474
[TBL] [Abstract][Full Text] [Related]
14. [Interindividual variation of pharmacokinetic disposition of and clinical responses to opioid analgesics in cancer pain patients].
Naito T; Kawakami J
Yakugaku Zasshi; 2015; 135(5):709-15. PubMed ID: 25948306
[TBL] [Abstract][Full Text] [Related]
15. Genetic mutations that prevent pain: implications for future pain medication.
Oertel B; Lötsch J
Pharmacogenomics; 2008 Feb; 9(2):179-94. PubMed ID: 18370847
[TBL] [Abstract][Full Text] [Related]
16. Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence.
Blum K; Chen ALC; Thanos PK; Febo M; Demetrovics Z; Dushaj K; Kovoor A; Baron D; Smith DE; Roy AK; Fried L; Chen TJH; Chapman E; Modestino EJ; Steinberg B; Badgaiyan RD
Front Biosci (Elite Ed); 2018 Jan; 10(1):175-196. PubMed ID: 28930612
[TBL] [Abstract][Full Text] [Related]
17. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
[TBL] [Abstract][Full Text] [Related]
18. Opioid addiction and misuse in adult and adolescent patients with cancer.
Pinkerton R; Hardy JR
Intern Med J; 2017 Jun; 47(6):632-636. PubMed ID: 28580748
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte opioid receptors as innovative biomarkers of osteoarthritic pain, for the assessment and risk management of opioid tailored therapy, before hip surgery, to prevent chronic pain and opioid tolerance/addiction development: OpMarkArt (Opioids-Markers-Arthroprosthesis) study protocol for a randomized controlled trial.
Malafoglia V; Celi M; Muscoli C; Ilari S; Lauro F; Giancotti LA; Morabito C; Feola M; Tarantino U; Raffaeli W
Trials; 2017 Dec; 18(1):605. PubMed ID: 29258584
[TBL] [Abstract][Full Text] [Related]
20. Opioid metabolism.
Smith HS
Mayo Clin Proc; 2009 Jul; 84(7):613-24. PubMed ID: 19567715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
